Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)

NCT04768920 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04768920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04768920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
Lead sponsor
University of Michigan
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 11, 2022
Completion date
August 18, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

substance dependence, substance use, substance use disorders